Marin Prpić
University of Zagreb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marin Prpić.
QJM: An International Journal of Medicine | 2017
Davor Kust; Marko Lucijanic; Kristina Urch; Ivan Šamija; Ivana Celap; Ivan Kruljac; Marin Prpić; Ivica Lucijanic; Neven Mateša; Ante Bolanča
Purpose : colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, and detection of new prognostic markers is mandatory for patients to receive optimal oncological treatment. The aim of the study was to assess clinical and prognostic value of red cell distribution width (RDW) in patients with CRC. Methods : RDW values in 90 patients with CRC undergoing surgery for primary disease were analyzed in pre- and postoperative setting, and correlated with clinical and hematological parameters. Results : Both pre- and postoperative RDW measurements were found to be associated with features of iron deficiency anemia, inflammatory response to tumor, advanced age and depth of tumor invasion. Optimal cutoff points were calculated to be 14% for preoperative and 13.6% for postoperative RDW measurements. Elevations in both pre- and postoperative RDW values had significant effects on survival in univariate and multivariate analyses. Effects were found to be independent of tumor related features, stage of the disease, development of anemia and aberrant inflammatory response to tumor. Conclusions : RDW is an integrative parameter reflecting tumor specific features and shows significant association with overall survival in patients with CRC. This is especially important in patients with stage 2 disease where elevation in preoperative RDW values can contribute to recognition of higher risk patients.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2017
Marin Prpić; Davor Kust; Ivan Kruljac; Lora Stanka Kirigin; Tomislav Jukić; Nina Dabelić; Ante Bolanča; Zvonko Kusić
The purpose of this study was to detect parameters that could serve as predictors of radioactive iodine (I‐131) ablation failure in patients with low‐risk and intermediate‐risk differentiated thyroid carcinoma (DTC).
Acta Clinica Belgica | 2016
Davor Kust; Ivan Kruljac; Ana Šverko Peternac; Jelena Ostojić; Marin Prpić; Dubravka Čaržavec; Petar Gaćina
To best of our knowledge, this is the first reported case of pericardial and pleural effusions combined with ascites, precipitated with severe sunitinib-induced hypothyroidism. A 58-year-old man presented in our emergency department due to dyspnoea and dry cough. Sixteen months earlier, the patient underwent left nephrectomy due to metastatic renal cell adenocarcinoma (RCC), and therapy with sunitinib was initiated postoperatively. Thyroid function was not assessed during the therapy. On admission, all laboratory findings were within normal range. Computed tomography of the chest detected voluminous bilateral pleural effusions and mild pericardial effusion, and echocardiography revealed pericardial effusion. Thoracocentesis was carried out three times, and cytological examination showed no signs of malignant cells. After assessment of the thyroid function, neglected hypothyroidism was registered. Substitution therapy with levothyroxine was initiated, and thyroid function normalised 2 weeks later. Few days after the last thoracocentesis, his condition suddenly got worse. Thoracocentesis was repeated, and microbiological analysis of the exudate came positive for Klebsiella pneumoniae and Streptococcus pneumoniae. Despite the implemented therapeutic measures, his clinical condition progressively deteriorated. The patient died 27 days after the admission, hospital-acquired pneumonia was identified as the cause of death. Our case emphasises the necessity of careful monitoring and management of side-effects in patients who receive sunitinib. Hypothyroidism is a known cause of pleural, pericardial and abdominal effusions, as reported in several case reports. Timely initiation of substitution levothyroxine therapy can decrease unnecessary pauses in the therapy with sunitinib, as well as prevent development of severe symptoms.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2018
Petar Suton; Marin Prpić; Marko Tarle; Matija Mamic; Iva Nikles; Ivica Lukšić
The purpose of our article was to describe a tertiary centers experience with patients with primarily surgically treated early‐stage intraoral cancer with a second primary malignancy confirmed during follow‐up.
Acta Clinica Croatica | 2017
Darko Breitenfeld; Davor Kust; Tomislav Breitenfeld; Marin Prpić; Marko Lucijanic; Davor Zibar; Vedran Hostić; Maja Franceschi; Ante Bolanča
Syphilis is a sexually transmitted, systemic disease caused by the spirochete bacterium Treponema pallidum. The most common mechanism of transmission is sexual intercourse. Although there are several hypotheses, the exact origin of the disease remains unknown. Newly published evidence suggests that the hypothesis supporting the theory of the American origin of the disease is the valid one. Among 1500 analyzed pathographies of composers and musicians, data on ten Anglo-American composers and jazz musicians having suffered from neurosyphilis (tertiary stage of the disease) were extracted for this report. In this group of Anglo-American composers and musicians, most of them died from progressive paralysis while still in the creative phase of life. Additionally, diagnoses of eleven other famous neurosyphilitic composers, as well as basic biographic data on ten less known composers that died from neurosyphilis-progressive paralysis are also briefly mentioned. In conclusion, neurosyphilis can cause serious neurological damage, as well as permanent disability or death, preventing further work and skill improvement.
Anticancer Research | 2014
Davor Kust; Marin Prpić; Jure Murgić; Marijana Jazvić; Blanka Jakšić; Dražena Krilić; Ante Bolanča; Zvonko Kusić
Acta Clinica Croatica | 2015
Tomislav Jukić; Michael B. Zimmermann; Roko Granić; Marin Prpić; Dražena Krilić; Vesna Jureša; Marijan Katalenić; Zvonko Kusić
Anticancer Research | 2015
Marijana Jazvić; Marin Prpić; Tomislav Jukić; Jure Murgić; Blanka Jakšić; Davor Kust; Angela Prgomet; Ante Bolanča; Zvonko Kusić
Endocrine | 2016
Marin Prpić; Ivan Kruljac; Davor Kust; Lora Stanka Kirigin; Tomislav Jukić; Nina Dabelić; Ante Bolanča; Zvonko Kusić
Anticancer Research | 2014
Ana Frobe; Glenn Jones; Tomislav Bokulić; Iva Mrčela; Mirjana Budanec; Jure Murgić; Blanka Jakšić; Marin Prpić; Ante Bolanča; Zvonko Kusić